The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Tasigna-Global Market Insights and Sales Trends 2024
Synopsis
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
The global Tasigna market size is expected to reach US$ 1200.7 million by 2029, growing at a CAGR of -5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Tasigna in various end use industries. The expanding demands from the Hospital, Drugs Store and Other, are propelling Tasigna market. 50mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 200mg segment is estimated at % CAGR for the next seven-year period.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tasigna, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tasigna market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tasigna market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tasigna sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tasigna covered in this report include Novartis. etc.
The global Tasigna market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Global Tasigna market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tasigna market, Segment by Type:
50mg
200mg
Other
Global Tasigna market, by Application
Hospital
Drugs Store
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tasigna manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tasigna in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
TASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia.
The global Tasigna market size is expected to reach US$ 1200.7 million by 2029, growing at a CAGR of -5.4% from 2023 to 2029. The market is mainly driven by the significant applications of Tasigna in various end use industries. The expanding demands from the Hospital, Drugs Store and Other, are propelling Tasigna market. 50mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 200mg segment is estimated at % CAGR for the next seven-year period.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Tasigna, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Tasigna market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Tasigna market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Tasigna sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Tasigna covered in this report include Novartis. etc.
The global Tasigna market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Novartis
Global Tasigna market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tasigna market, Segment by Type:
50mg
200mg
Other
Global Tasigna market, by Application
Hospital
Drugs Store
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Tasigna manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Tasigna in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Tasigna Market Overview
1.1 Tasigna Product Overview
1.2 Tasigna Market Segment by Type
1.2.1 50mg
1.2.2 200mg
1.2.3 Other
1.3 Global Tasigna Market Size by Type
1.3.1 Global Tasigna Market Size Overview by Type (2018-2029)
1.3.2 Global Tasigna Historic Market Size Review by Type (2018-2023)
1.3.3 Global Tasigna Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Tasigna Sales Breakdown by Type (2018-2023)
1.4.2 Europe Tasigna Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Tasigna Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Tasigna Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Tasigna Sales Breakdown by Type (2018-2023)
2 Global Tasigna Market Competition by Company
2.1 Global Top Players by Tasigna Sales (2018-2023)
2.2 Global Top Players by Tasigna Revenue (2018-2023)
2.3 Global Top Players by Tasigna Price (2018-2023)
2.4 Global Top Manufacturers Tasigna Manufacturing Base Distribution, Sales Area, Product Type
2.5 Tasigna Market Competitive Situation and Trends
2.5.1 Tasigna Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Tasigna Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Tasigna as of 2022)
2.7 Date of Key Manufacturers Enter into Tasigna Market
2.8 Key Manufacturers Tasigna Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Tasigna Status and Outlook by Region
3.1 Global Tasigna Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Tasigna Historic Market Size by Region
3.2.1 Global Tasigna Sales in Volume by Region (2018-2023)
3.2.2 Global Tasigna Sales in Value by Region (2018-2023)
3.2.3 Global Tasigna Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Tasigna Forecasted Market Size by Region
3.3.1 Global Tasigna Sales in Volume by Region (2024-2029)
3.3.2 Global Tasigna Sales in Value by Region (2024-2029)
3.3.3 Global Tasigna Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Tasigna by Application
4.1 Tasigna Market Segment by Application
4.1.1 Hospital
4.1.2 Drugs Store
4.1.3 Other
4.2 Global Tasigna Market Size by Application
4.2.1 Global Tasigna Market Size Overview by Application (2018-2029)
4.2.2 Global Tasigna Historic Market Size Review by Application (2018-2023)
4.2.3 Global Tasigna Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Tasigna Sales Breakdown by Application (2018-2023)
4.3.2 Europe Tasigna Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Tasigna Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Tasigna Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Tasigna Sales Breakdown by Application (2018-2023)
5 North America Tasigna by Country
5.1 North America Tasigna Historic Market Size by Country
5.1.1 North America Tasigna Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Tasigna Sales in Volume by Country (2018-2023)
5.1.3 North America Tasigna Sales in Value by Country (2018-2023)
5.2 North America Tasigna Forecasted Market Size by Country
5.2.1 North America Tasigna Sales in Volume by Country (2024-2029)
5.2.2 North America Tasigna Sales in Value by Country (2024-2029)
6 Europe Tasigna by Country
6.1 Europe Tasigna Historic Market Size by Country
6.1.1 Europe Tasigna Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Tasigna Sales in Volume by Country (2018-2023)
6.1.3 Europe Tasigna Sales in Value by Country (2018-2023)
6.2 Europe Tasigna Forecasted Market Size by Country
6.2.1 Europe Tasigna Sales in Volume by Country (2024-2029)
6.2.2 Europe Tasigna Sales in Value by Country (2024-2029)
7 Asia-Pacific Tasigna by Region
7.1 Asia-Pacific Tasigna Historic Market Size by Region
7.1.1 Asia-Pacific Tasigna Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Tasigna Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Tasigna Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Tasigna Forecasted Market Size by Region
7.2.1 Asia-Pacific Tasigna Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Tasigna Sales in Value by Region (2024-2029)
8 Latin America Tasigna by Country
8.1 Latin America Tasigna Historic Market Size by Country
8.1.1 Latin America Tasigna Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Tasigna Sales in Volume by Country (2018-2023)
8.1.3 Latin America Tasigna Sales in Value by Country (2018-2023)
8.2 Latin America Tasigna Forecasted Market Size by Country
8.2.1 Latin America Tasigna Sales in Volume by Country (2024-2029)
8.2.2 Latin America Tasigna Sales in Value by Country (2024-2029)
9 Middle East and Africa Tasigna by Country
9.1 Middle East and Africa Tasigna Historic Market Size by Country
9.1.1 Middle East and Africa Tasigna Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Tasigna Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Tasigna Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Tasigna Forecasted Market Size by Country
9.2.1 Middle East and Africa Tasigna Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Tasigna Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Tasigna Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novartis Tasigna Products Offered
10.1.5 Novartis Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Tasigna Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Tasigna Industrial Chain Analysis
11.4 Tasigna Market Dynamics
11.4.1 Tasigna Industry Trends
11.4.2 Tasigna Market Drivers
11.4.3 Tasigna Market Challenges
11.4.4 Tasigna Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Tasigna Distributors
12.3 Tasigna Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
